Close
Menu
Tables or Figures
Biotage Q3 FY20 Sales Change. Comparison
Report:
Instrument Business Outlook Volume 29 - Issue 17
/ Chapter:
Third Quarter Results: Biotage, Bio-Techne, HORIBA and Shimadzu
Source: Science and Medicine Group
Bio-Techne Q1 FY21 Sales Comparison by Divisions
Report:
Instrument Business Outlook Volume 29 - Issue 17
/ Chapter:
Third Quarter Results: Biotage, Bio-Techne, HORIBA and Shimadzu
Source: Science and Medicine Group
HORIBA Q3 FY20 Operating Profit Comparison of Process & Environmental and Scientific Instruments (SI)
Report:
Instrument Business Outlook Volume 29 - Issue 17
/ Chapter:
Third Quarter Results: Biotage, Bio-Techne, HORIBA and Shimadzu
Source: Science and Medicine Group
Shimadzu AMI H1 FY21 End-Market Sales Breakdown
Notes: The graph reflects Shimadzu AMI's H1 FY21 end-market sales.
Report:
Instrument Business Outlook Volume 29 - Issue 17
/ Chapter:
Third Quarter Results: Biotage, Bio-Techne, HORIBA and Shimadzu
Source: Science and Medicine Group
Shimadzu AMI Q2 FY21 Sales Comparison of Key Models and Other Models
Report:
Instrument Business Outlook Volume 29 - Issue 17
/ Chapter:
Third Quarter Results: Biotage, Bio-Techne, HORIBA and Shimadzu
Source: Science and Medicine Group
South Korea GOVERD by Performance Sectors, 2019
Report:
Instrument Business Outlook Volume 29 - Issue 17
/ Chapter:
Region Watch
Source:
Ministry of Science and ICT, Korea Institute of S&T Evaluation and Planning
South Korea GOVERD by Selected Future Emerging & Technologies, 2019
Report:
Instrument Business Outlook Volume 29 - Issue 17
/ Chapter:
Region Watch
Source:
Ministry of Science and ICT, Korea Institute of S&T Evaluation and Planning
To the Top